COMMUNIQUÉS West-GlobeNewswire

Teladoc Health to Announce Second Quarter 2026 Financial Results
15/07/2026
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026, after the market [...]
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
15/07/2026
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
15/07/2026
CHASKA, Minn., July 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that [...]
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
15/07/2026
BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter [...]
Rakovina Therapeutics Announces $1.5 Million Private Placement
15/07/2026
VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)- [...]
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
15/07/2026
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2026 financial results on Wednesday, August 5, [...]
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
15/07/2026
First patients dosed in OPTIMAL-e 1 Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent’s Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier prostate cancer [...]
Surrozen to Present at Upcoming Healthcare Investor Conference
15/07/2026
SOUTH SAN FRANCISCO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program
15/07/2026
Peer-reviewed journal's News section highlights the Company’s continued progress toward a fully implantable total artificial heart TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: [...]
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026
15/07/2026
ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
Medicare Covers Online Therapy in New York: MMHC's Medicare-Enrolled Therapists Now Accepting New Patients Statewide at $0 to $27 Per Session
15/07/2026
Every therapist at Manhattan Mental Health Counseling is enrolled in Medicare and bills Medicare directly; no referral required, no annual session limits, exact cost confirmed before session one, and first sessions [...]
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
15/07/2026
ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive [...]
Neutrolis Announces New England Journal of Medicine Publication Demonstrating First Clinical Evidence for NET-Degrading Therapy in Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused by DNASE1L3 Deficiency
15/07/2026
Treatment with investigational DNASE1L3 analog NTR-441, which degrades neutrophil extracellular traps (NETs), resulted in rapid clinical improvement in a patient with treatment-refractory SLE Results provide first human [...]
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
15/07/2026
RADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026 [...]
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
15/07/2026
WESTLAKE VILLAGE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2026
15/07/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 6th to 10th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total [...]
Rainwater Drake Dental Announces Name Change From Hawkins Rainwater Dental Group
15/07/2026
The West Little Rock practice retains its location, doctor team and range of dental services after more than 30 years in the community. Little Rock, AR, July 15, 2026 (GLOBE NEWSWIRE) -- Rainwater Drake Dental, a West [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine xx - 2025
15/07/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 6 au 10 juillet 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease
15/07/2026
Study in highly translatable non-human primate models demonstrate how selective PKA-II modulation in combination with levodopa improved motor benefit while reducing dyskinesia Development candidate, SB-0110, now [...]

Pages